Tags

Type your tag names separated by a space and hit enter

Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial.
Patient Educ Couns. 2019 03; 102(3):424-428.PE

Abstract

OBJECTIVE

To investigate the effect of including an online decision aid (DA) during prostate cancer treatment counseling on decisional regret and information satisfaction in a one-year follow-up.

METHODS

Within a cluster RCT, 18 Dutch hospitals were randomized to DA counseling or care-as-usual, patients (n = 382) initially completed questionnaires directly after treatment decision making. Six and twelve months later regret (Decisional Regret Scale) and information satisfaction (SCIP-B) were assessed. Anxious and depressive symptoms (HADS) was included as possible covariate.

RESULTS

After 12 months, 43 participants (15%) regretted their treatment choice and 105 participants (36%) were dissatisfied with the information that was received at the time of decision-making, regardless of being exposed to the DA. Anxious and depressive symptoms at follow-up were associated with regret and information dissatisfaction.

CONCLUSION

No long-term benefical effects emerged from DA usage compared to patients who underwent standard counseling.

PRACTICE IMPLICATIONS

During PCa treatment counseling, healthcare providers should be aware of anxious and depressive symptoms.

Authors+Show Affiliations

Department of Social Psychology, Tilburg University, Tilburg, The Netherlands; Radboud Institute for Health Sciences, Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: maarten.cuypers@radboudumc.nl.Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands. Electronic address: R.Lamers@etz.nl.Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands. Electronic address: P.Kil@etz.nl.CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands; Department of Research, Comprehensive Cancer Organisation Netherlands, Eindhoven, The Netherlands; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: L.vandePoll@iknl.nl.Institute for Computing and Information Sciences (iCIS) & Social and Cultural Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands. Electronic address: Marieke.deVries@ru.nl.

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

30314830

Citation

Cuypers, Maarten, et al. "Longitudinal Regret and Information Satisfaction After Deciding On Treatment for Localized Prostate Cancer With or Without a Decision Aid. Results at One-year Follow-up in the PCPCC Trial." Patient Education and Counseling, vol. 102, no. 3, 2019, pp. 424-428.
Cuypers M, Lamers RED, Kil PJM, et al. Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial. Patient Educ Couns. 2019;102(3):424-428.
Cuypers, M., Lamers, R. E. D., Kil, P. J. M., van de Poll-Franse, L. V., & de Vries, M. (2019). Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial. Patient Education and Counseling, 102(3), 424-428. https://doi.org/10.1016/j.pec.2018.10.006
Cuypers M, et al. Longitudinal Regret and Information Satisfaction After Deciding On Treatment for Localized Prostate Cancer With or Without a Decision Aid. Results at One-year Follow-up in the PCPCC Trial. Patient Educ Couns. 2019;102(3):424-428. PubMed PMID: 30314830.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Longitudinal regret and information satisfaction after deciding on treatment for localized prostate cancer with or without a decision aid. Results at one-year follow-up in the PCPCC trial. AU - Cuypers,Maarten, AU - Lamers,Romy E D, AU - Kil,Paul J M, AU - van de Poll-Franse,Lonneke V, AU - de Vries,Marieke, Y1 - 2018/10/04/ PY - 2018/01/24/received PY - 2018/10/02/revised PY - 2018/10/03/accepted PY - 2018/10/14/pubmed PY - 2019/9/7/medline PY - 2018/10/14/entrez KW - Decision aid KW - Patient-reported outcomes KW - Prostate cancer KW - Regret KW - Satisfaction KW - Shared decision making KW - Treatment SP - 424 EP - 428 JF - Patient education and counseling JO - Patient Educ Couns VL - 102 IS - 3 N2 - OBJECTIVE: To investigate the effect of including an online decision aid (DA) during prostate cancer treatment counseling on decisional regret and information satisfaction in a one-year follow-up. METHODS: Within a cluster RCT, 18 Dutch hospitals were randomized to DA counseling or care-as-usual, patients (n = 382) initially completed questionnaires directly after treatment decision making. Six and twelve months later regret (Decisional Regret Scale) and information satisfaction (SCIP-B) were assessed. Anxious and depressive symptoms (HADS) was included as possible covariate. RESULTS: After 12 months, 43 participants (15%) regretted their treatment choice and 105 participants (36%) were dissatisfied with the information that was received at the time of decision-making, regardless of being exposed to the DA. Anxious and depressive symptoms at follow-up were associated with regret and information dissatisfaction. CONCLUSION: No long-term benefical effects emerged from DA usage compared to patients who underwent standard counseling. PRACTICE IMPLICATIONS: During PCa treatment counseling, healthcare providers should be aware of anxious and depressive symptoms. SN - 1873-5134 UR - https://www.unboundmedicine.com/medline/citation/30314830/Longitudinal_regret_and_information_satisfaction_after_deciding_on_treatment_for_localized_prostate_cancer_with_or_without_a_decision_aid__Results_at_one_year_follow_up_in_the_PCPCC_trial_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0738-3991(18)30843-7 DB - PRIME DP - Unbound Medicine ER -